Current Hypertension Reports

, Volume 15, Issue 6, pp 638–649

Epidemiology of Pulmonary Arterial Hypertension

Pulmonary Hypertension (Z-C Jing, Section Editor)

DOI: 10.1007/s11906-013-0397-5

Cite this article as:
Jiang, X. & Jing, ZC. Curr Hypertens Rep (2013) 15: 638. doi:10.1007/s11906-013-0397-5


The epidemiology of pulmonary arterial hypertension (PAH) has changed over the last decade. Remarkable advances in understanding the pathobiology and clinical care required in PAH have resulted in improved quality of life and survival. Despite such important progress, the long-term rate of survival is still unacceptable. The epidemiology of PAH could not be easily generalized globally, due to the fact that nearly all of the present data has been gathered from Western, multicenter, prospective registries. There are potentially marked differences in PAH patients from Western and Eastern populations, and from developed and developing countries. Therefore, it is clear that more registry data will be needed to address novel questions emerging with improved knowledge of PAH.


Pulmonary arterial hypertension PAH Epidemiology Prognosis Heritable PAH Connective tissue disease Congenital heart disease CHD Human immunodeficiency virus HIV Portopulmonary hypertension PoPH Drugs Toxins Schistosomiasis Pulmonary veno-occlusive disease PVOD 

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Thrombosis Medicine Center, State Key Laboratory of Cardiovascular Disease, Fu Wai HospitalPeking Union Medical College and Chinese Academy of Medical SciencesBeijingChina

Personalised recommendations